HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

RU24858

a glucocorticoid; structure in first source

Also Known As:

RU 24858; RU-24858

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Fluorinated Steroids: 32
      - Dexamethasone: 23151
        Desoximetasone: 55
        RU24858: 1
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienediols
        Desoximetasone: 55
        RU24858: 1

Experts

1.	Hanausek, Margaret: 1 article (06/2014)
2.	Junco, Jacob J: 1 article (06/2014)
3.	Kowalczyk, Magdalena C: 1 article (06/2014)
4.	Kowalczyk, Piotr: 1 article (06/2014)
5.	Slaga, Thomas J: 1 article (06/2014)
6.	Sosnowska, Renata: 1 article (06/2014)
7.	Tolstykh, Olga: 1 article (06/2014)
8.	Walaszek, Zbigniew: 1 article (06/2014)

Related Diseases

1.	Neoplasms (Cancer) 06/01/2014 - "DES, FA and RU24858 reversed TPA-induced epidermal hyperplasia and proliferation, while RU24782 treatment had no effect on these markers of skin tumor promotion. " 06/01/2014 - "The effects of dissociated glucocorticoids RU24858 and RU24782 on TPA-induced skin tumor promotion biomarkers in SENCAR mice."
2.	Inflammation (Inflammations) 06/01/2014 - "These findings show that RU24858 but not RU24782 reduced TPA-induced epidermal hyperplasia, proliferation, and inflammation, while both compounds reversed c-jun mRNA increases in the skin."
3.	Hyperplasia 06/01/2014 - "DES, FA and RU24858 reversed TPA-induced epidermal hyperplasia and proliferation, while RU24782 treatment had no effect on these markers of skin tumor promotion. " 06/01/2014 - "These findings show that RU24858 but not RU24782 reduced TPA-induced epidermal hyperplasia, proliferation, and inflammation, while both compounds reversed c-jun mRNA increases in the skin."

Related Drugs and Biologics

1.	Biomarkers (Surrogate Marker)
2.	Messenger RNA (mRNA)
3.	Glucocorticoids
4.	RU24782